hnRNPA2B1 inhibits the exosomal export of miR-503 in endothelial cells
Related Experiment Video
Updated: Dec 31, 2025

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Jennifer Pérez-Boza1,2, Amandine Boeckx1, Michele Lion1
1Molecular Angiogenesis Laboratory, GIGA Research, ULiege, B34, Avenue de l'Hôpital, 1, 4000, Liège, Belgium.
Abstract:
The chemotherapeutic drug epirubicin increases the exosomal export of miR-503 in endothelial cells. To understand the mechanisms behind this process, we transfected endothelial cells with miR-503 carrying a biotin tag. Then, we pulled-down the proteins interacting with miR-503 and studied their role in microRNA exosomal export. A total of four different binding partners were identified by mass spectrometry and validated by western blotting and negative controls, among them ANXA2 and hnRNPA2B1. Using knock-down systems combined with pull-down analysis, we determined that epirubicin mediates the export of miR-503 by disrupting the interaction between hnRNPA2B1 and miR-503. Then, both ANXA2 and miR-503 are sorted into exosomes while hnRNPA2B1 is relocated into the nucleus. The combination of these processes culminates in the increased export of miR-503. These results suggest, for the first time, that RNA-binding proteins can negatively regulate the exosomal sorting of microRNAs.
Related Concept Videos
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
MicroRNAs
MicroRNAs
Regulation of Nuclear Protein Sorting
Regulation of Angiogenesis and Blood Supply

